Functional Systems Regulation Theory offers a systems oriented framework for medicine assisted psychotherapy and trauma therapy. Rather than treating medicines as cures or shortcuts, FSRT situates them within nervous system capacity, relational safety, and environmental stability. Healing is not determined by the substance alone, but by whether the system can metabolize what is introduced. Regulation, integration, and containment are the determining variables.

Within Functional Systems Regulation Theory, medicines are not treated as shortcuts, cures, or fixed stages in a healing process.

They are understood as temporary scaffolds that may support access, stabilization, or reorganization when sufficient attunement, containment, and integration are already present within the system.

The same medicine can function very differently depending on nervous system capacity, relational safety, environmental stability, and cultural context. What supports regulation in one system may overwhelm another. What facilitates integration in one phase may destabilize in another.

FSRT does not organize care around substances. It organizes care around system capacity.

The central question is not which phase someone is in. The question is whether the system can metabolize what the medicine introduces.

The inclusion of any specific medicine reflects clinical context and therapeutic judgment, not universal endorsement.

What follows is not a treatment protocol. It is a systems oriented clinical map describing how medicine assisted psychotherapy and related interventions may be situated across the FSRT clinical arc when the surrounding conditions are sufficient to support integration.

Phase One Entry and System Assessment

Supporting Orientation Without Overwhelm.

In the initial phase, the central question remains simple and decisive. Is there sufficient safety for contact.

Medicine work in this phase, when used at all, is conservative and strictly attunement guided. The goal is orientation rather than insight or catharsis. Activation is reduced only enough to allow contact with self, environment, and relationship.

Ketamine may be used to soften hyperarousal, reduce affective flooding, or allow brief and tolerable access to internal states that are otherwise unreachable. When held carefully, it can help the system experience contact without collapse.

Kambô, when culturally appropriate and skillfully held, may function as a physiological boundary marker or reset. However, it often exceeds capacity if introduced prematurely and is approached cautiously within FSRT.

Medicines such as psilocybin, MDMA, ayahuasca, ibogaine, or 5-MEO are generally avoided at this stage unless the system demonstrates clear and sustained stability, containment, and integration capacity.

FSRT treats early medicine use as support for orientation, not a doorway into depth.

Phase Two Stabilization and Regulatory Capacity Building

Borrowing Regulation to Expand Capacity.

As safety and predictability increase, medicine work may support stabilization by temporarily reducing threat perception or widening the window of tolerance. In this phase, medicines function less as insight generators and more as regulatory amplifiers.

Ketamine often plays a central role here, supporting nervous system flexibility and interrupting entrenched stress patterns. It allows the system to experience coherence or rest before those states are reliably accessible without support.

MDMA may be introduced selectively to support relational safety, trust, and co regulation, particularly when attachment injury limits the system’s ability to feel safe in contact.

Kambô may continue to be used by some systems as a grounding or somatic boundary practice, though timing, pacing, and cultural humility remain essential.

Across this phase, regulation is borrowed before it becomes self-sustaining. Attunement governs frequency and dosage rather than momentum or expectation.

Phase Three Meaning Making and Pattern Recognition

Supporting Insight Without Destabilization.

Once regulatory capacity allows reflective awareness, medicine work may support perspective shifting, emotional access, and narrative flexibility. The system can now observe itself without collapse.

Psilocybin often becomes relevant here, supporting pattern recognition, symbolic insight, and the softening of rigid cognitive or relational loops.

MDMA may deepen emotional honesty and relational clarity, particularly around attachment and developmental trauma.

Ketamine may continue to support integration by allowing distance from entrenched identity structures.

Ayahuasca or ibogaine may enter the work for some systems at this stage, though FSRT emphasizes that these medicines introduce significant systemic load and require robust preparation, containment, integration, and environmental stability.

Within FSRT, insight is only valuable when it can be metabolized. Attunement determines whether meaning becomes integration or another form of overload.

Phase Four Reorganization and Skill Integration

Reconsolidating Experience and Identity.

As regulation and insight converge, medicine work may support emotional reconsolidation, identity reorganization, and the integration of previously fragmented experience. The focus shifts from understanding patterns to living differently under stress.

MDMA may support the repair of relational templates and the rehearsal of new responses within a felt sense of safety.

Psilocybin may assist in reorganizing meaning and values beyond survival based identities.

Ketamine may support flexibility during periods of transition or repatterning.

Ibogaine, when used, often functions as a profound pattern interruptive scaffold, reorganizing long standing patterns related to addiction, trauma, or identity. Its use demands extensive preparation and integration and is never treated as routine.

Ayahuasca and 5-MEO may support experiences of coherence, surrender, or existential re-orientation, but FSRT holds these medicines as reorganizing forces rather than therapeutic necessities.

Phase Five Maintenance Growth and Actualization

Intentional Use Without Dependence.

In the final phase, medicine work becomes intermittent, intentional, and increasingly rare. Growth is no longer defined by symptom reduction, but by the system’s capacity to remain flexible, connected, and responsive across changing conditions.

Psilocybin or ayahuasca may support meaning making, purpose, or life transitions when held within strong integration frameworks.

Ketamine may be used occasionally to support perspective or prevent rigidity during periods of stress.

5-MeO DMT, when approached, is treated as an existential rather than clinical scaffold, requiring significant maturity, preparation, and containment.

Kambô may remain part of some individuals’ ongoing somatic or ritual practice.

FSRT emphasizes that continued growth does not require continued medicine use. Coherence becomes self-sustaining through relationship, rhythm, and meaning.